Prevalence of Antibodies against Seasonal Influenza A and B Viruses in Children in Netherlands

ABSTRACT To gain insight into the age at which children become infected with influenza viruses for the first time, we analyzed the seroprevalence of antibodies against influenza viruses in children 0 to 7 years of age in the Netherlands. Serum samples were collected during a cross-sectional population-based study in 2006 and 2007 and were tested for the presence of antibodies against influenza A/H1N1, A/H3N2, and B viruses representative of viruses present in previous influenza seasons using the hemagglutination inhibition assay. The seroprevalence of antibodies to influenza virus was higher in children 1 to 6 months of age than in children 7 to 12 months of age, which likely reflects the presence of maternally derived antibodies. The proportion of study subjects >1 year of age with detectable antibodies against influenza viruses gradually increased with age until they reached the age of 6 years, when they all had antibodies to at least one influenza A virus. These findings may have implications for the development of vaccination strategies aiming at the protection of young children against seasonal and/or pandemic influenza virus infection.

[1]  E. Harris,et al.  Clinical attack rate and presentation of pandemic H1N1 influenza versus seasonal influenza A and B in a pediatric cohort in Nicaragua. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  P. Tamma,et al.  Influenza infection and vaccination in pregnant women , 2010, Expert review of respiratory medicine.

[3]  S. Arifeen,et al.  Influenza immunization in pregnancy--antibody responses in mothers and infants. , 2010, The New England journal of medicine.

[4]  L. Simonsen,et al.  Assessing the burden of paediatric influenza in Europe: the European Paediatric Influenza Analysis (EPIA) project , 2010, European Journal of Pediatrics.

[5]  L. Finelli,et al.  Emergence of a novel swine-origin influenza A (H1N1) virus in humans. , 2009, The New England journal of medicine.

[6]  G. Rimmelzwaan,et al.  Yearly influenza vaccinations: a double-edged sword? , 2009, The Lancet. Infectious diseases.

[7]  D. Fleming,et al.  Fatal Cases of Influenza A in Childhood , 2009, PloS one.

[8]  H. D. de Melker,et al.  Second national serum bank for population-based seroprevalence studies in the Netherlands. , 2009, The Netherlands journal of medicine.

[9]  R. Schmidt-Ott,et al.  Seroprevalence of influenza A and B in German infants and adolescents , 2009, Medical Microbiology and Immunology.

[10]  Guus F. Rimmelzwaan,et al.  Het influenzaseizoen 2007/'08 in Nederland: antigene variatie, resistentie tegen oseltamivir en de vaccinsamenstelling voor het seizoen 2008/'09 , 2008 .

[11]  B. Luce,et al.  Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States. , 2008, Vaccine.

[12]  R. Mikolajczyk,et al.  Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases , 2008, PLoS medicine.

[13]  C. Bridges,et al.  Vaccine Effectiveness Against Medically Attended, Laboratory-Confirmed Influenza Among Children Aged 6 to 59 Months, 2003–2004 , 2007, Pediatrics.

[14]  A. Osterhaus,et al.  [The 2005-2006 influenza season in the Netherlands and the vaccine composition for the 2006-2007 season]. , 2006, Nederlands tijdschrift voor geneeskunde.

[15]  T. Heikkinen,et al.  Cost-effectiveness of influenza vaccination of healthy children. , 2006, Vaccine.

[16]  T. Heikkinen,et al.  Should healthy children be vaccinated against influenza? , 2006, European Journal of Pediatrics.

[17]  Guus F. Rimmelzwaan,et al.  Het influenzaseizoen 2004/'05 in Nederland met de grootste epidemie van de laatste 5 jaar, door virusvariant A/California, en de vaccinsamenstelling voor het seizoen 2005/'06. , 2005 .

[18]  M. Kolczak,et al.  Effectiveness of the 2003–2004 Influenza Vaccine Among Children 6 Months to 8 Years of Age, With 1 vs 2 Doses , 2005, Pediatrics.

[19]  R. Belshe,et al.  Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination , 2004, The Pediatric infectious disease journal.

[20]  A. Osterhaus,et al.  [2000/01 influenza season and the vaccine composition for the season 2001/'02]. , 2001, Nederlands tijdschrift voor geneeskunde.

[21]  B. Rao,et al.  Seroepidemiology of influenza in Pune, India. , 2001, The Indian journal of medical research.

[22]  L. Simonsen,et al.  The Japanese experience with vaccinating schoolchildren against influenza. , 2001, The New England journal of medicine.

[23]  A. Osterhaus,et al.  [Influenza season 1999/2000 and vaccine composition for the season 2000/01]. , 2000, Nederlands tijdschrift voor geneeskunde.

[24]  J. Oxford,et al.  Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study , 2000, BJOG : an international journal of obstetrics and gynaecology.

[25]  E F Mitchel,et al.  The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. , 2000, The New England journal of medicine.

[26]  R. Davis,et al.  Influenza and the rates of hospitalization for respiratory disease among infants and young children. , 2000, The New England journal of medicine.

[27]  A. Osterhaus,et al.  [Influenza season 1998/99; composition of vaccine for 1999/2000]. , 1999, Nederlands tijdschrift voor geneeskunde.

[28]  Y. Kanegae,et al.  Evolutionary pattern of the hemagglutinin gene of influenza B viruses isolated in Japan: cocirculating lineages in the same epidemic season , 1990, Journal of virology.

[29]  A. Kendal,et al.  Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. , 1990, Virology.

[30]  E. Ayoub,et al.  Effect of passive maternal antibody on influenza illness in children: a prospective study of influenza A in mother-infant pairs. , 1987, The Pediatric infectious disease journal.

[31]  P. Griffiths,et al.  Antibody against viruses in maternal and cord sera: specific antibody is concentrated on the fetal side of the circulation , 1982, Journal of Hygiene.

[32]  J P Fox,et al.  Influenzavirus infections in Seattle families, 1975-1979. I. Study design, methods and the occurrence of infections by time and age. , 1982, American journal of epidemiology.

[33]  A. Frank,et al.  Patterns of shedding of myxoviruses and paramyxoviruses in children. , 1981, The Journal of infectious diseases.

[34]  J. Puck,et al.  Protection of infants from infection with influenza A virus by transplacentally acquired antibody. , 1980, The Journal of infectious diseases.

[35]  C B Hall,et al.  Viral shedding patterns of children with influenza B infection. , 1979, The Journal of infectious diseases.

[36]  R. Couch,et al.  Interpandemic influenza in the Houston area, 1974-76. , 1978, The New England journal of medicine.

[37]  J. Quilligan,et al.  Influenza vaccination in children. , 1961, American journal of diseases of children.

[38]  R. Schmidt-Ott,et al.  revalence of influenza A and B antibodies in pregnant omen and their offspring , 2009 .

[39]  A. Osterhaus,et al.  [Influenza season 2007/'08 in the Netherlands: antigenic variation, oseltamivir resistance and vaccine composition for the 2008/'09 season]. , 2008, Nederlands tijdschrift voor geneeskunde.

[40]  A. Osterhaus,et al.  [The 2006/'07 influenza season in the Netherlands and the vaccine composition for the 2007/'08 season]. , 2007, Nederlands tijdschrift voor geneeskunde.

[41]  A. Osterhaus,et al.  [The influenza season 2004/'05 in the Netherlands with the largest epidemic of the last 5 years caused by the virus variant A/California and the composition of the vaccine for the season 2005/'06]. , 2005, Nederlands tijdschrift voor geneeskunde.

[42]  A. Osterhaus,et al.  Haemagglutination-inhibiting antibody to influenza virus. , 2003, Developments in biologicals.

[43]  A. Osterhaus,et al.  [The 2002/2003 influenza season in the Netherlands and the vaccine composition for the 2003/2004 season]. , 2003, Nederlands tijdschrift voor geneeskunde.

[44]  Lead Visual Information Specialist , 2001 .